Terms: = Liver cancer AND CD79A, ENSG00000105369, 973, P11912, MB-1, IGA AND Treatment
78 results:
1. Adjuvant treatment with Cordyceps sinensis for lung cancer: A systematic review and meta-analysis of randomized controlled trials.
Wang C; Wang J; Qi Y
J Ethnopharmacol; 2024 Jun; 327():118044. PubMed ID: 38484953
[TBL] [Abstract] [Full Text] [Related]
2. Celiac Disease: Promising Biomarkers for Follow-Up.
Hrunka M; Janda L; Šťastná M; Pinkasová T; Pecl J; Kunovský L; Dítě P; Jabandžiev P
J Gastrointestin Liver Dis; 2023 Dec; 32(4):536-544. PubMed ID: 38147608
[TBL] [Abstract] [Full Text] [Related]
3. Efficacy and safety of Xiao-ai-ping injection add-on therapy to chemotherapy in patients with non-small cell lung cancer: A systematic review and meta-analysis.
Li A; Liu S; Zhang H; Lin M; Guo L; Yuan C; Li Z; Xu J; Wang T
Medicine (Baltimore); 2023 Oct; 102(40):e35483. PubMed ID: 37800773
[TBL] [Abstract] [Full Text] [Related]
4. Low-density lipoprotein cholesterol and risk of hepatocellular carcinoma: a Mendelian randomization and mediation analysis.
Cao J; Wang Z; Zhu M; Huang Y; Jin Z; Xiong Z
Lipids Health Dis; 2023 Jul; 22(1):110. PubMed ID: 37525197
[TBL] [Abstract] [Full Text] [Related]
5. Tertiary lymphoid structures predict the prognosis and immunotherapy response of cholangiocarcinoma.
Shang T; Jiang T; Lu T; Wang H; Cui X; Pan Y; Xu M; Pei M; Ding Z; Feng X; Lin Y; Li X; Tan Y; Feng F; Dong H; Wang H; Dong L
Front Immunol; 2023; 14():1166497. PubMed ID: 37234171
[TBL] [Abstract] [Full Text] [Related]
6. Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by iga-FcR signalling.
Kotsiliti E; Leone V; Schuehle S; Govaere O; Li H; Wolf MJ; Horvatic H; Bierwirth S; Hundertmark J; Inverso D; Zizmare L; Sarusi-Portuguez A; Gupta R; O'Connor T; Giannou AD; Shiri AM; Schlesinger Y; Beccaria MG; Rennert C; Pfister D; Öllinger R; Gadjalova I; Ramadori P; Rahbari M; Rahbari N; Healy ME; Fernández-Vaquero M; Yahoo N; Janzen J; Singh I; Fan C; Liu X; Rau M; Feuchtenberger M; Schwaneck E; Wallace SJ; Cockell S; Wilson-Kanamori J; Ramachandran P; Kho C; Kendall TJ; Leblond AL; Keppler SJ; Bielecki P; Steiger K; Hofmann M; Rippe K; Zitzelsberger H; Weber A; Malek N; Luedde T; Vucur M; Augustin HG; Flavell R; Parnas O; Rad R; Pabst O; Henderson NC; Huber S; Macpherson A; Knolle P; Claassen M; Geier A; Trautwein C; Unger K; Elinav E; Waisman A; Abdullah Z; Haller D; Tacke F; Anstee QM; Heikenwalder M
J Hepatol; 2023 Aug; 79(2):296-313. PubMed ID: 37224925
[TBL] [Abstract] [Full Text] [Related]
7. Early changes in immunoglobulin G levels during immune checkpoint inhibitor treatment are associated with survival in hepatocellular carcinoma patients.
Balcar L; Bauer D; Pomej K; Meischl T; Mandorfer M; Reiberger T; Trauner M; Scheiner B; Pinter M
PLoS One; 2023; 18(4):e0282680. PubMed ID: 37027398
[TBL] [Abstract] [Full Text] [Related]
8. Association of Direct-Acting Antiviral Therapy With liver and Nonliver Complications and Long-term Mortality in Patients With Chronic Hepatitis C.
Ogawa E; Chien N; Kam L; Yeo YH; Ji F; Huang DQ; Cheung R; Nguyen MH
JAMA Intern Med; 2023 Feb; 183(2):97-105. PubMed ID: 36508196
[TBL] [Abstract] [Full Text] [Related]
9. treatment patterns for hepatocellular carcinoma in patients with Child-Pugh class B and their impact on survival: A Korean nationwide registry study.
Jeon D; Song GW; Lee HC; Shim JH
Liver Int; 2022 Dec; 42(12):2830-2842. PubMed ID: 36287103
[TBL] [Abstract] [Full Text] [Related]
10. Effects of Fufang Banmao Capsule Associated with Sorafenib on liver Function, Immune Status, Quality of Life Improvement, and Survival in Patients with Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study.
Lai X; Wang A
Comput Intell Neurosci; 2022; 2022():6336107. PubMed ID: 36052044
[TBL] [Abstract] [Full Text] [Related]
11. In-Circuit High-Frequency Jet Ventilation for Radiological Tumor Ablation: A Case Series.
Salih T; Elgie L; Hari B; Williams B; Thomas RM; Bandula S; Walkden M; Sultan P; McPherson K; Jenkins K
A A Pract; 2022 Aug; 16(8):e01608. PubMed ID: 35960937
[TBL] [Abstract] [Full Text] [Related]
12. The double-edged sword of probiotic supplementation on gut microbiota structure in
Nabavi-Rad A; Sadeghi A; Asadzadeh Aghdaei H; Yadegar A; Smith SM; Zali MR
Gut Microbes; 2022; 14(1):2108655. PubMed ID: 35951774
[TBL] [Abstract] [Full Text] [Related]
13. Effects of Chinese Herbal Formula on Immune Function and Nutritional Status of Breast cancer Patients.
Liu M
Comput Math Methods Med; 2022; 2022():5900024. PubMed ID: 35872927
[TBL] [Abstract] [Full Text] [Related]
14. Effects of mFOLFOX6 regimen combined with carrelizumab on immune function and prognosis in patients with microsatellite instability colorectal cancer.
Sun J; Yao N; Lu P; Wang Y
Cell Mol Biol (Noisy-le-grand); 2022 Feb; 67(5):356-362. PubMed ID: 35818232
[TBL] [Abstract] [Full Text] [Related]
15. Peripheral B-cell dysregulation is associated with relapse after long-term quiescence in patients with multiple sclerosis.
Marsh-Wakefield F; Juillard P; Ashhurst TM; Juillard A; Shinko D; Putri GH; Read MN; McGuire HM; Byrne SN; Hawke S; Grau GE
Immunol Cell Biol; 2022 Jul; 100(6):453-467. PubMed ID: 35416319
[TBL] [Abstract] [Full Text] [Related]
16. Gut inflammation in CVID: causes and consequences.
Andersen IM; Jørgensen SF
Expert Rev Clin Immunol; 2022 Jan; 18(1):31-45. PubMed ID: 34978241
[TBL] [Abstract] [Full Text] [Related]
17. Symmetrical Skin Lesions on the Gluteal Region in a Patient with Anti-Laminin-332 Mucous Membrane Pemphigoid.
Maki N; Demitsu T; Nagato H; Okada O; Yoneda K; Hashimoto T; Hasunuma N; Osada I; Manabe M
Acta Dermatovenerol Croat; 2021 Jul; 29(2):105-107. PubMed ID: 34477077
[TBL] [Abstract] [Full Text] [Related]
18. Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B.
Lee HW; Cho YY; Lee H; Lee JS; Kim SU; Park JY; Kim DY; Ahn SH; Kim BK; Park SY
Hepatol Int; 2021 Oct; 15(5):1083-1092. PubMed ID: 34402025
[TBL] [Abstract] [Full Text] [Related]
19. treatment challenges and health conditions among people living with HIV with or without substance use disorder in the Russian Federation.
Kuznetsov S; Eremin A; Zaytseva E; Young B; Basova A; Paice A; Marin O; de Los Rios P; Okoli C
AIDS Care; 2022 Oct; 34(10):1276-1281. PubMed ID: 34369217
[TBL] [Abstract] [Full Text] [Related]
20. A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial.
McEvoy NL; Clarke JL; Mc Elvaney OJ; Mc Elvaney OF; Boland F; Hyland D; Geoghegan P; Donnelly K; Friel O; Cullen A; Collins AM; Fraughen D; Martin-Loeches I; Hennessy M; Laffey JG; Mc Elvaney NG; Curley GF
Trials; 2021 Apr; 22(1):288. PubMed ID: 33874981
[TBL] [Abstract] [Full Text] [Related]
[Next]
